Clonal T-cell-mediated erythroid failure: redefining pure red cell aplasia across the T-cell large granular lymphocytic leukemia spectrum
Pure red cell aplasia (PRCA) is a clinically important manifestation of T-cell large granular lymphocytic leukemia (T-LGLL), yet severe erythroid failure may occur when the circulating clone is small and conventional leukemic thresholds are not met. We review evidence suggesting possible biological links among reactive cytotoxic T-cell expansion, T-cell clones of uncertain significance, low-burden clonal disease, and overt T-LGLL, with PRCA highlighting the clinical significance of clonal T-cell pathogenicity. STAT3/JAK-STAT activation, apoptosis resistance, cytotoxic effector programs, antigen-driven T-cell receptor selection, marrow inflammation, and host clonal hematopoiesis provide complementary mechanisms. Causal attribution should integrate confirmed PRCA, exclusion of competing causes, immunophenotypic and T-cell receptor clonality, and appropriately interpreted molecular findings. Cyclosporine and cyclophosphamide remain central therapies; methotrexate is phenotype-dependent, whereas sirolimus and JAK inhibition are rational options for refractory disease. Future studies should prioritize clone-resolved multi-omics, standardized response endpoints, and prospective molecularly stratified registries. This framework prioritizes pathogenicity over numerical clone burden.
Authors
- 王芳婷
- Jiawen Yu
- Yanyu Zhang
- Jingwen Qin
Institutions
- First Affiliated Hospital of Dalian Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fimmu.2026.1997692
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00